Lakewood-Amedex Biotherapeutics Announces World-Renowned Expert David G. Armstrong, M.D., Ph.D., as Study Chair for Phase 2a Trial of Nu-3 in Infected Diabetic Foot Ulcers
Go back to Lakewood-Amedex Biotherapeutics Announces World-Renowned Expert David G. Armstrong, M.D., Ph.D., as Study Chair for Phase 2a Trial of Nu-3 in Infected Diabetic Foot Ulcers| (NASDAQ: LABT) | Delayed: 1.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.86 | 52 Week High | $ | |||
| Open | $1.86 | 52 Week Low | $ | |||
| Day High | $1.86 | P/E | N/A | |||
| Day Low | $1.86 | EPS | $ | |||
| Volume | 2,693 | |||||
